Research output per year
Research output per year
Personal profile
Keywords
- Cancer
Fingerprint
Dive into the research topics where Peter Kamper is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG–NLG phase II BVB trial
Fosså, A., Molin, D., Bröckelmann, P. J., Schneider, G., Schnetzke, U., Linderoth, J., Kamper, P. M. H., Leppä, S. M., Meissner, J., Schaub, V., Lia, K., Fuchs, M., Borchmann, P. & Böll, B., Mar 2025, In: HemaSphere. 9, 3, e70099.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Letter › peer-review
Open Access -
Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity
Andersen, M. D., Wolter, K., Enemark, M. H., Lauridsen, K. L., Hamilton-Dutoit, S. J., Starklint, J., d’Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P., 2025, In: Leukemia & Lymphoma. 66, 4, p. 656-667 12 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal Involvement
Andersen, M. D., Wolter, K., Enemark, M. B. H., Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P., Jan 2025, In: European Journal of Haematology. 114, 1, p. 173-185 13 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access1 Citation (Scopus) -
Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort Study
Godtfredsen, S. J., Yonis, H., Baech, J., Al-Hussainy, N. R., Riddersholm, S., Kober, L., Schou, M., Christensen, J. H., Hutchings, M., Dahl-Sørensen, R. B., Kamper, P., Dietrich, C. E., Andersen, M. P., Torp-Pedersen, C., Sogaard, P., El-Galaly, T. C. & Kragholm, K. H., Feb 2025, In: European Journal of Haematology. 114, 2, p. 343-352 10 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
German Hodgkin Study Group, Swiss Group for Clinical Cancer Research, Arbeitsgemeinschaft Medikamentöse Tumortherapie, Nordic Lymphoma Group & Australasian Leukaemia and Lymphoma Group, Jul 2024, In: The Lancet. 404, 10450, p. 341-352 12 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access35 Citations (Scopus)